Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk

Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk

In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline’s Arexvy vaccine to include adults aged 50 to 59 who face a heightened risk from respiratory syncytial virus (RSV) due to underlying health conditions. This expanded approval marks a significant move in Canada’s battle against RSV, a respiratory virus that, […]

Clinuvel Pharmaceuticals submits NDA for SCENESSE to Health Canada, aiming to treat rare genetic disorder

Clinuvel Pharmaceuticals submits NDA for SCENESSE to Health Canada, aiming to treat rare genetic disorder

Clinuvel Pharmaceuticals has filed a New Drug Submission to Health Canada for its innovative therapy, SCENESSE, marking a potential breakthrough for Canadian patients suffering from erythropoietic protoporphyria (EPP), a rare genetic disorder that triggers severe pain and burns from light exposure. If approved, SCENESSE will be the first treatment for EPP in Canada, offering a […]

Health Canada approves KEYTRUDA and Enfortumab Vedotin for advanced urothelial cancer

Health Canada approves KEYTRUDA and Enfortumab Vedotin for advanced urothelial cancer

Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced that Health Canada has granted approval for KEYTRUDA (pembrolizumab) in combination with enfortumab vedotin for the treatment of adult patients with unresectable locally advanced or metastatic urothelial cancer (mUC) who have not received prior systemic therapy for this condition. This decision […]

Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod

Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod

Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given its approval for the next-generation Dexcom G7 Continuous Glucose Monitoring System. The product is intended for people aged two and above who have any type of diabetes. Dexcom Canada, however, has mentioned that the device is not […]

Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment

Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment

Sun Pharma Canada, a subsidiary of Sun Pharmaceutical Industries, has secured Health Canada’s approval for their pioneering acne treatment, WINLEVI (clascoterone cream 1%). This marks the first approval of an androgen receptor inhibitor for topical treatment of acne vulgaris in patients aged 12 and older, presenting a groundbreaking advancement in acne treatments for Canadian patients […]

Lupin gets Health Canada approval for generic Spiriva for COPD treatment

Lupin gets Health Canada approval for generic Spiriva for COPD treatment

Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium bromide inhalation powder) for the treatment of chronic obstructive pulmonary disease (COPD) in Canada. Tiotropium Bromide Inhalation Powder is used as a long-term maintenance bronchodilator for patients with COPD, including […]

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis. Lupin said that Rymti is available in Canada as an […]

Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada

Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada

Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer drug Revlimid. The launch was announced earlier this month by the Indian pharma company’s Canadian subsidiary — Natco Pharma (Canada). PrNAT-LENADLIDOMIDE in combination with dexamethasone is approved by Health Canada for the treatment of multiple myeloma in […]

Vivimed Labs exports first shipment of Famotidine tablets to Canada

Vivimed Labs exports first shipment of Famotidine tablets to Canada

Vivimed Labs, an Indian pharma company, said that it has exported the first shipment of its Famotidine tablets 40mg and 20mg to Canada. Famotidine is a histamine H2 receptor antagonist, which has been approved by Health Canada for the relief of heartburn, indigestion, stomach upset, sour stomach because of excess stomach acid, hyperacidity, and acid […]